We are live on
!
Find out more
Moleculin Biotech
MBRX
MBRX
0.7516
USD
-0.0236
3.04%
At close
Updated
Sep 15, 4:00 PM EDT
Pre-market
After hours
0.7668
+0.0152
2.02%
1 day
-3.04%
5 days
-2.53%
1 month
23.82%
3 months
-72.27%
6 months
-63.34%
Year to date
-79.24%
1 year
-91.91%
5 years
-99.93%
10 years
-99.99%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 26 |
GCP
26
GSA Capital Partners
London,
United Kingdom
| – | -$114K | -83 | Closed |
|
| 27 |
27
Goldman Sachs
New York
| – | -$94K | -69 | Closed |
|
| 28 |
VF
28
Virtu Financial
New York
| – | -$93K | -67 | Closed |
|
| 29 |
WIC
29
Whitegate Investment Counselors
Concord,
New Hampshire
| – | -$62K | -45 | Closed |
|
| 30 |
TRCT
30
Tower Research Capital (TRC)
New York
| – | -$8.17K | -7 | Closed |
|
| 31 |
CFO
31
CVA Family Office
Denver,
Colorado
| – | -$2K | -1 | Closed |
|